Literature DB >> 11440793

Fibrillar beta-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease.

Y Matsuoka1, M Picciano, J La Francois, K Duff.   

Abstract

Beta-amyloid is one of the most significant features of Alzheimer's disease, and has been considered to play a pivotal role in neurodegeneration through an unknown mechanism. However, it has been noted that beta-amyloid accumulation is associated with markers of oxidative stress including protein oxidation (Smith et al., 1997), lipid peroxidation (Mark et al., 1997; Sayre et al., 1997), advanced glycation end products (Smith et al., 1994), and oxidation of nucleic acids (Nunomura et al., 1999). Furthermore, studies from cultured cells have shown that beta-amyloid leads to an increase in hydrogen peroxide levels (Behl et al., 1994), and the production of reactive oxygen intermediates (Harris et al., 1995). Taken together, this evidence supports the idea that beta-amyloid plays a key role in oxidative stress-evoked neuropathology. In this study, we examined the induction of oxidative stress in response to amyloid load in a mouse model of Alzheimer's disease. The mice carrying mutant amyloid precursor protein and presenilins-1 (Goate et al., 1991; Hardy, 1997), develops beta-amyloid deposits at 10-12 weeks of age and show several features of the human disease (Holcomb et al., 1998; Matsuoka et al., 2001; McGowan et al., 1999; Takeuchi et al., 2000; Wong et al., 1999). Both 3-nitrotyrosine and 4-hydroxy-2-nonenal (protein and lipid oxidative stress markers, respectively) associate strongly with fibrillar beta-amyloid, but not with diffuse (thioflavine S negative) beta-amyloid, and the levels increase in relation to the age-associated increase in fibrillar amyloid load.From these data we suggest that fibrillar beta-amyloid is associated with oxidative damage which may influence disease progression in the Alzheimer's disease brain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11440793     DOI: 10.1016/s0306-4522(01)00115-4

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  42 in total

Review 1.  Oxidative stress, cell cycle, and neurodegeneration.

Authors:  Jeffrey A Klein; Susan L Ackerman
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 2.  Calcium and mitochondrial reactive oxygen species generation: how to read the facts.

Authors:  Vera Adam-Vizi; Anatoly A Starkov
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.

Authors:  Belén G Ramírez; Cristina Blázquez; Teresa Gómez del Pulgar; Manuel Guzmán; María L de Ceballos
Journal:  J Neurosci       Date:  2005-02-23       Impact factor: 6.167

4.  Granulocyte-macrophage colony-stimulating factor antibody suppresses microglial activity: implications for anti-inflammatory effects in Alzheimer's disease and multiple sclerosis.

Authors:  P Hemachandra Reddy; Maria Manczak; Wei Zhao; Kazuhiro Nakamura; Christopher Bebbington; Geoffrey Yarranton; Peizhong Mao
Journal:  J Neurochem       Date:  2009-10-14       Impact factor: 5.372

5.  Hippocampal Proteomic Analysis Reveals Distinct Pathway Deregulation Profiles at Early and Late Stages in a Rat Model of Alzheimer's-Like Amyloid Pathology.

Authors:  Sonia Do Carmo; Gogce Crynen; Tiffany Paradis; Jon Reed; M Florencia Iulita; Adriana Ducatenzeiler; Fiona Crawford; A Claudio Cuello
Journal:  Mol Neurobiol       Date:  2017-05-13       Impact factor: 5.590

Review 6.  Getting to the Heart of Alzheimer Disease.

Authors:  Joshua M Tublin; Jeremy M Adelstein; Federica Del Monte; Colin K Combs; Loren E Wold
Journal:  Circ Res       Date:  2019-01-04       Impact factor: 17.367

7.  Longitudinal CSF isoprostane and MRI atrophy in the progression to AD.

Authors:  M J de Leon; L Mosconi; J Li; S De Santi; Y Yao; W H Tsui; E Pirraglia; K Rich; E Javier; M Brys; L Glodzik; R Switalski; L A Saint Louis; D Pratico
Journal:  J Neurol       Date:  2007-11-14       Impact factor: 4.849

Review 8.  Adverse stress, hippocampal networks, and Alzheimer's disease.

Authors:  Sarah M Rothman; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2009-11-27       Impact factor: 3.843

9.  Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease.

Authors:  Maria Manczak; Peizhong Mao; Kazuhiro Nakamura; Christopher Bebbington; Byung Park; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2009-07-19       Impact factor: 6.150

Review 10.  Antioxidant treatment in Alzheimer's disease: current state.

Authors:  Yossi Gilgun-Sherki; Eldad Melamed; Daniel Offen
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.